Outcome of the 32nd Annual General Meeting of the Company.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
26-Sep-2025
Download PDF
Medicamen Biotech
Outcome of the 32nd Annual General Meeting of the Company.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]